0000899243-21-005096.txt : 20210205
0000899243-21-005096.hdr.sgml : 20210205
20210205184600
ACCESSION NUMBER: 0000899243-21-005096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210203
FILED AS OF DATE: 20210205
DATE AS OF CHANGE: 20210205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bodenrader Mark
CENTRAL INDEX KEY: 0001830371
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39311
FILM NUMBER: 21597804
MAIL ADDRESS:
STREET 1: C/O CEREVEL THERAPEUTICS HOLDINGS INC.
STREET 2: 131 DARTMOUTH STREET SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001805387
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 844-304-2048
MAIL ADDRESS:
STREET 1: 131 DARTMOUTH STREET
STREET 2: SUITE 502
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II
DATE OF NAME CHANGE: 20200303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-03
0
0001805387
Cerevel Therapeutics Holdings, Inc.
CERE
0001830371
Bodenrader Mark
C/O CEREVEL THERAPEUTICS HOLDINGS, INC.
222 JACOBS STREET, SUITE 200
CAMBRIDGE
MA
02141
0
1
0
0
See Remarks
Stock Option (Right to Buy)
12.70
2021-02-03
4
A
0
90000
0.00
A
2031-02-03
Common Stock
90000
90000
D
25% of this option shall vest and become exercisable on February 3, 2022, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Vice President, Finance and Chief Accounting Officer
/s/ Mark Bodenrader
2021-02-05